Transcatheter Aortic Valve Replacement (TAVR) is a minimally invasive procedure used to treat aortic valve stenosis, a condition in which the aortic valve becomes narrowed and restricts blood flow from the heart. Instead of open-heart surgery, TAVR involves the insertion of a catheter through a blood vessel, typically in the groin or chest, and guiding a replacement valve to the site of the narrowed valve. The replacement valve is usually made of biological material and is expanded to replace the diseased valve. TAVR is particularly beneficial for patients who are at high risk for open-heart surgery or have other health conditions that make them unsuitable candidates for traditional surgery. This procedure offers shorter recovery times, reduced complications, and improved quality of life for patients with aortic valve stenosis. However, it still requires careful evaluation and selection to ensure its suitability for each individual patient.